4/A//SEC Filing
Parker Katherine 4/A
Accession 0001179110-18-012205
CIK 0001235007other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:17 PM ET
Size
6.1 KB
Accession
0001179110-18-012205
Insider Transaction Report
Form 4/AAmended
ENDOCYTE INCECYT
Parker Katherine
VP of Human Resources
Transactions
- Sale
Common Stock
2018-10-05$15.55/sh−6,771$105,316→ 70,869 total
Holdings
- 1,200(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the sale of 6,771 shares in multiple transactions ranging in price from $15.1300 to $15.9200, resulting in a weighted-average sale price per share of $15.5540. The 6,771 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 15,000 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- [F2]Includes 520 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2018 that were inadvertently omitted from the amount of securities beneficially owned by the reporting person as reported on the Form 4 filed by the reporting person on October 9, 2018.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeother
Related Parties
1- filerCIK 0001633299
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:17 PM ET
- Size
- 6.1 KB